Recipient of federal assistance · BROOKLINE, MA

KEYLICON BIOSCIENCES INC

KEYLICON BIOSCIENCES INC received $1.4M in federal grants and other assistance in FY2026, on 5 actions. It has no federal contracts in the loaded years. Its largest awarding agency was National Institutes of Health ($1.4M).

Assistance · FY2026
$1.4M
New awards
4
Actions
5
UEI
UXSKUT48A7W3
Location
BROOKLINE, MA
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 1.4MFY2026

By type

  1. Grants$1.4M100%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.855 · Allergy and Infectious Diseases Research$628.7K44%
  2. 93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research$400K28%
  3. 93.286 · Discovery and Applied Research for Technological Innovations to Improve Human Health$400K28%

Awarding agencies

  1. National Institutes of Health$1.4M100%
    Department of Health and Human Services

Largest awards

  1. EXTENDED IN SITU PRODUCTION OF GLUCOCEREBROSIDASE (GCASE) FOR THE TREATMENT OF GAUCHER DISEASE - PROJECT SUMMARY/ABSTRACT KEYLICON…$400K
    93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Aug 21, 2026 – Aug 21, 2026· R43DK146746
  2. IMPROVING THE STABILITY OF SARNA LNP FORMULATIONS TO OVERCOME COLD CHAIN CHALLENGES - RNA VACCINES HAVE TRANSFORMED THE LANDSCAPE OF…$400K
    93.286 · Discovery and Applied Research for Technological Innovations to Improve Human Health· National Institutes of Health· Project grant· Sep 7, 2026 – Sep 7, 2026· R43EB038819
  3. LOW DOSE MULTIVALENT INFLUENZA VACCINE VIA MODIFIED SELF-AMPLIFYING RNA - PROJECT SUMMARY/ABSTRACT SEASONAL INFLUENZA REMAINS A MAJOR…$314.4K
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Jul 29, 2026 – Sep 22, 2026· R43AI197306
  4. MULTIVALENT VACCINE AGAINST LYME DISEASE VIA MODIFIED SELF-AMPLIFYING RNA - PROJECT SUMMARY/ABSTRACT LYME DISEASE, THE MOST COMMON…$314.4K
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Jul 20, 2026 – Jul 20, 2026· R43AI197345

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2026.